NCT02929576
Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer
Phase: Phase 3
Role: Collaborator
Start: Sep 30, 2016
Completion: Not specified